Aducanumab for Alzheimer disease: The amyloid hypothesis moves from bench to bedside

Authors

Erik S. Musiek, Washington University School of Medicine in St. Louis
Teresa Gomez-Isla, Massachusetts General Hospital
David M Holtzman, Washington University School of Medicine in St. Louis

Journal

Journal of clinical investigation

Publication Date

10-15-2021

Volume

131

Issue

20

First Page

e154889

Document Type

Open Access Publication

DOI

10.1172/JCI154889

Rights and Permissions

Musiek ES, Gomez-Isla T, Holtzman DM. Aducanumab for Alzheimer disease: the amyloid hypothesis moves from bench to bedside. J Clin Invest. 2021 Oct 15;131(20):e154889. doi: 10.1172/JCI154889. © 2021, American Society for Clinical Investigation

Recommended Citation

Musiek, Erik S.; Gomez-Isla, Teresa; and Holtzman, David M, "Aducanumab for Alzheimer disease: The amyloid hypothesis moves from bench to bedside." Journal of clinical investigation. 131, 20. e154889 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11221